Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKKB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,856
Award facts
- Contract value 100% obligated
- $17,855.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,855.78 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order carries no set-aside designation, reflecting a fully competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen's parent entity, Cencora, Inc., is a leading pharmaceutical distributor serving federal government agencies with an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA contract vehicle enables Cencora and its subsidiaries to supply critical pharmaceutical commodities to military treatment facilities, veterans' healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions globally. This specific delivery order for Ozempic, a diabetes medication, exemplifies the company's role in supporting federal medical procurement needs through its established federal supply chain relationships.
Quick answers
Who was awarded contract SPE2DR26FAKKB?
SPE2DR26FAKKB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FAKKB worth?
The government has obligated $17,856 on SPE2DR26FAKKB.
Is contract SPE2DR26FAKKB an order under another contract?
Yes. SPE2DR26FAKKB is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKKB competed?
The extent of competition for SPE2DR26FAKKB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award